NCT03520062View on ClinicalTrials.gov

The Effect of Liraglutide on Pancreatic Hormones and Its Size

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

January 1, 2020

Conditions
Obesity
Interventions
DRUG

Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml

Treatment with Liraglutide (3.0mg per day) for \~6 weeks

Trial Locations (1)

2650

Department of Endocrinology, Hvidovre

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Nicolai Jacob Wewer Albrechtsen

OTHER

NCT03520062 - The Effect of Liraglutide on Pancreatic Hormones and Its Size | Biotech Hunter | Biotech Hunter